You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GR-MD-02

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatic Impairment Trial in Rialto, Miami, San Antonio (belapectin)

Completed
  • Hepatic Impairment
  • Rialto, California
  • +3 more
Mar 24, 2022

Nonalcoholic Steatohepatitis Trial in Fort Sam Houston (GR-MD-02, Placebo)

Completed
Has Results
  • Nonalcoholic Steatohepatitis
  • GR-MD-02
  • Placebo
  • Fort Sam Houston, Texas
    Brooke Army Medical Center
Oct 6, 2020

Psoriasis Trial in San Antonio (GR-MD-02)

Completed
Has Results
  • Psoriasis
  • GR-MD-02
  • San Antonio, Texas
    Brooke Army Medical Ctr.
Sep 3, 2020

Hypertension, Portal Trial in United States (GR-MD-02, Placebo)

Completed
Has Results
  • Hypertension, Portal
  • GR-MD-02
  • Placebo
  • Los Angeles, California
  • +45 more
Oct 6, 2020

Metastatic Melanoma Trial in Portland (1 mg/kg GR-MD-02, 2 mg/kg GR-MD-02, 4 mg/kg GR-MD-02)

Completed
  • Metastatic Melanoma
  • 1 mg/kg GR-MD-02
  • +4 more
  • Portland, Oregon
    Providence Portland Medical Center
Mar 19, 2019

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Chronic Kidney Disease, Type 2 Diabetes, Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

Not yet recruiting
  • Chronic Kidney Disease
  • +2 more
  • Concord, California
  • +73 more
Nov 9, 2023

Obesity Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Birmingham, Alabama
  • +106 more
Jan 24, 2023

Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Enzalutamide, Docetaxel, Prednisolone)

Active, not recruiting
Has Results
  • Metastatic Castration Resistant Prostate Cancer
  • Linz, Austria
  • +88 more
Dec 22, 2022

Atherosclerotic Cardiovascular Disease Trial in Worldwide (NNC0385-0434 A 15 mg, NNC0385-0434 A 40 mg, Placebo I A (for

Active, not recruiting
  • Atherosclerotic Cardiovascular Disease
  • NNC0385-0434 A 15 mg
  • +6 more
  • Palm Springs, California
  • +42 more
Mar 21, 2022

Breast Cancer Trial in Worldwide (gas chromatography / tandem mass spectometry)

Completed
Has Results
  • Breast Cancer
  • gas chromatography / tandem mass spectometry
  • Saint-Cloud, France
  • +23 more
Sep 27, 2021

Palmoplantar Psoriasis, Genital Psoriasis Trial in Worldwide (Deucravacitinib, Placebo)

Not yet recruiting
  • Palmoplantar Psoriasis
  • Genital Psoriasis
  • Birmingham, Alabama
  • +24 more
Sep 12, 2023

Sickle Cell Disease Trial in Vadodara, Nagpur, Pune (NUV001 - IR, NUV001 - GR, Placebo)

Not yet recruiting
  • Sickle Cell Disease
  • NUV001 - IR
  • +2 more
  • Vadodara, Gujarat, India
  • +2 more
Mar 17, 2023

Glaucoma Trial in United States (Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%)

Active, not recruiting
  • Glaucoma
  • Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%
  • Mission Hills, California
  • +20 more
Jan 6, 2023

Melanoma Trial in Worldwide (Pembrolizumab, Quavonlimab, Vibostolimab)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +4 more
  • Los Angeles, California
  • +34 more
Jan 25, 2023

Glioma Trial in Dallas, Houston, San Antonio (Rhenium Liposome Treatment)

Recruiting
  • Glioma
  • Rhenium Liposome Treatment
  • Dallas, Texas
  • +2 more
Nov 3, 2021

Diabetes, Type 2 Trial in Worldwide (NNC0480-0389, Semaglutide, Placebo (NNC080-0389))

Recruiting
  • Diabetes Mellitus, Type 2
  • Buena Park, California
  • +95 more
Mar 31, 2022

Anemia, Iron Deficiency, Pregnancy Anemia Trial (Venofer 200 MG Per 10 ML Injection, Ferinject)

Not yet recruiting
  • Anemia, Iron Deficiency
  • Pregnancy Anemia
  • (no location specified)
Oct 4, 2023

Migraine Trial in Worldwide (Lu AG09222, Placebo)

Active, not recruiting
  • Migraine
  • Lu AG09222
  • Placebo
  • Oceanside, California
  • +27 more
Dec 7, 2022

Free Mucogingival Grafts, Gingival Recession, Root Coverage Trial in Murcia (Buccal muco-gingival tissue graft, Palatal

Recruiting
  • Free Mucogingival Grafts
  • +3 more
  • Buccal muco-gingival tissue graft
  • Palatal connective tissue graft
  • Murcia, Spain
    Centro Odontologico Del Sureste Slp
May 6, 2023

Haemophilia A and B With and Without Inhibitors Trial in Worldwide (Concizumab)

Recruiting
  • Haemophilia A and B With and Without Inhibitors
  • San Diego, California
  • +55 more
Feb 2, 2023

Congenital Myotonic Dystrophy Trial in Worldwide (Tideglusib)

Enrolling by invitation
  • Congenital Myotonic Dystrophy
  • Little Rock, Arkansas
  • +10 more
Nov 15, 2021

Acute Myeloid Leukemia, High-risk Myelodysplastic Syndrome Trial in Poland, United States (RVU120(SEL120))

Recruiting
  • Acute Myeloid Leukemia
  • High-risk Myelodysplastic Syndrome
  • Miami, Florida
  • +6 more
Nov 5, 2021

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seongnam-si (nab-paclitaxel plus gemcitabine-cisplatin)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • nab-paclitaxel plus gemcitabine-cisplatin
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    CHA Bundang Medical Center
Oct 27, 2022